Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1978 Jun;37(3):218–224. doi: 10.1136/ard.37.3.218

Cyclic AMP and prostaglandin E in perfusates of rat hind paws during the development of adjuvant arthritis

M J Parnham 1, I L Bonta 1, M J P Adolfs 1
PMCID: PMC1000210  PMID: 210725

Abstract

The contralateral uninjected hind paws of rats which had been injected with Freund's complete (FCA) or incomplete (FIA) adjuvant 10,14, 18, or 22 days previously were perfused under urethane anaesthesia using a stainless steel coaxial catheter. In one series of experiments cyclic AMP (cAMP) levels were determined after a 2-hour perfusion. cAMP levels were also determined in rats treated on days 16-22 with either prostaglandin E1 (PGE1) (500 μg/kg per day subcutaneously) or saline. When compared with control rats injected with FIA, after 22 days, cAMP levels in FCA-injected rats fell between days 10 and 18 and then rose between days 18 and 22. After PGE1 treatment, paw volume on day 22 increased in rats injected with FCA, but cAMP levels were not significantly altered when compared with day 22 FCA-injected controls treated with saline.

In a second series of experiments, using a slightly modified perfusion method, PG levels in extracts of 30-minute perfusates were determined after chromatography and bioassay. Protein levels and paw volume were also measured. No PGF was detectable in any perfusate. Changes in PGE levels in FCA-injected animals paralleled changes in paw volume, increasing from day 14 and reaching a maximum on day 22. Both parameters remained unchanged in FIA-injected rats. Protein levels in perfusates from FCA-injected animals were significantly greater than FIA-injected controls only on day 22.

We suggest that the early changes in cAMP reflect the infiltration of activated leucocytes into the inflamed joint and that the increase in PGE is attributable to lysosomal enzyme activity. Later increases in cAMP are attributable both to the increasing PGE levels and to other changes in cellular activation. We suggest that high levels of PGE contribute to tissue damage which is reflected in raised protein levels.

Full text

PDF
218

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adolfs M. J., Bonta I. L., Parnham M. J. Cyclic AMP production during adjuvant-induced arthritis in rats [proceedings]. Br J Pharmacol. 1977 Mar;59(3):439P–440P. [PMC free article] [PubMed] [Google Scholar]
  2. Anderson A. J. Lysosomal enzyme activity in rats with adjuvant-induced arthritis. Ann Rheum Dis. 1970 May;29(3):307–313. doi: 10.1136/ard.29.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aspinall R. L., Cammarata P. S. Effect of prostaglandin E2 on adjuvant arthritis. Nature. 1969 Dec 27;224(5226):1320–1321. doi: 10.1038/2241320a0. [DOI] [PubMed] [Google Scholar]
  4. BURSTEIN N. A., WAKSMAN B. H. THE PATHOGENESIS OF ADJUVANT DISEASE IN THE RAT. I. A HISTOLOGIC STUDY OF EARLY LESIONS IN THE JOINTS AND SKIN. Yale J Biol Med. 1964 Dec;37:177–194. [PMC free article] [PubMed] [Google Scholar]
  5. Bonta I. L., Parnham M. J., Van Vliet L. Combination of theophylline and prostaglandin E1 as inhibitors of the adjuvant-induced arthritis syndrome of rats. Ann Rheum Dis. 1978 Jun;37(3):212–217. doi: 10.1136/ard.37.3.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bonta I. L., Parnham M. J., van Vliet L., Vincent J. E. Mutual enhancement of the effects of prostaglandin E1 and theophylline on the Freud adjuvant-induced arthritis syndrome of rats [proceedings]. Br J Pharmacol. 1977 Mar;59(3):438P–439P. [PMC free article] [PubMed] [Google Scholar]
  7. Bourne H. R., Lichtenstein L. M., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cyclic AMP. Science. 1974 Apr 5;184(4132):19–28. doi: 10.1126/science.184.4132.19. [DOI] [PubMed] [Google Scholar]
  8. Bult H., Parnham M. J., Bonta I. L. Bioassay by cascade superfusion using a highly sensitive laminar flow technique. J Pharm Pharmacol. 1977 Jun;29(6):369–370. doi: 10.1111/j.2042-7158.1977.tb11338.x. [DOI] [PubMed] [Google Scholar]
  9. Ferreira S. H., De Souza Costa F. A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substances. Eur J Pharmacol. 1976 Oct;39(2):379–381. doi: 10.1016/0014-2999(76)90147-3. [DOI] [PubMed] [Google Scholar]
  10. Franklin T. J., Foster S. J. Leakage of cyclic AMP from human diploid fibroblasts in tissue culture. Nat New Biol. 1973 Nov 28;246(152):119–120. doi: 10.1038/newbio246119a0. [DOI] [PubMed] [Google Scholar]
  11. Gemsa D., Steggemann L., Menzel J., Till G. Release of cyclic AMP from macrophages by stimulation with prostaglandins. J Immunol. 1975 Apr;114(4):1422–1424. [PubMed] [Google Scholar]
  12. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gilmore N., Vane J. R., Wyllie J. H. Prostaglandins released by the spleen. Nature. 1968 Jun 22;218(5147):1135–1140. doi: 10.1038/2181135a0. [DOI] [PubMed] [Google Scholar]
  14. Ignarro L. J., Slywka J. Changes in liver lysosome fragility, erythrocyte membrane stability, and local and systemic lysosomal enzyme levels in adjuvant-induced polyarthritis. Biochem Pharmacol. 1972 Mar 15;21(6):875–886. doi: 10.1016/0006-2952(72)90131-1. [DOI] [PubMed] [Google Scholar]
  15. Kuehl F. A., Jr, Humes J. L., Egan R. W., Ham E. A., Beveridge G. C., Van Arman C. G. Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature. 1977 Jan 13;265(5590):170–173. doi: 10.1038/265170a0. [DOI] [PubMed] [Google Scholar]
  16. Kunze H., Vogt W. Significance of phospholipase A for prostaglandin formation. Ann N Y Acad Sci. 1971 Apr 30;180:123–125. doi: 10.1111/j.1749-6632.1971.tb53191.x. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. PEARSON C. M. EXPERIMENTAL MODELS IN RHEUMATOID DISEASE. Arthritis Rheum. 1964 Feb;7:80–86. doi: 10.1002/art.1780070111. [DOI] [PubMed] [Google Scholar]
  19. Parnham M. J., Sneddon J. M. The influence of metyrapone on the synthesis and release of prostaglandins from the pregnant rat uterus in vitro. Br J Pharmacol. 1975 Dec;55(4):535–539. doi: 10.1111/j.1476-5381.1975.tb07429.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Perper R. J., Sanda M., Stecher V. J., Oronsky A. L. Physiologic and pharmacologic alterations of rat leukocyte chemotaxis (Cx) in vivo. Ann N Y Acad Sci. 1975 Jun 13;256:190–209. doi: 10.1111/j.1749-6632.1975.tb36047.x. [DOI] [PubMed] [Google Scholar]
  21. REGOLI D., VANE J. R. A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN. Br J Pharmacol Chemother. 1964 Oct;23:351–359. doi: 10.1111/j.1476-5381.1964.tb01591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. ROCHA E SILVA M., ANTONIO A. Release of bradykinin and the mechanism of production of a "thermic edema (45 degrees C)" in the rat's paw. Med Exp Int J Exp Med. 1960;3:371–382. [PubMed] [Google Scholar]
  23. Robinson D. R., McGuire M. B., Levine L. Prostaglandins in the rheumatic diseases. Ann N Y Acad Sci. 1975 Jun 13;256:318–329. doi: 10.1111/j.1749-6632.1975.tb36058.x. [DOI] [PubMed] [Google Scholar]
  24. Robinson D. R., Tashjian A. H., Jr, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest. 1975 Nov;56(5):1181–1188. doi: 10.1172/JCI108195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Teitz C. C., Chrisman O. D. The effect of salicylate and chloroquine on prostaglandin-induced articular damage in the rabbit knee. Clin Orthop Relat Res. 1975 May;(108):264–274. doi: 10.1097/00003086-197505000-00039. [DOI] [PubMed] [Google Scholar]
  26. VANE J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1957 Sep;12(3):344–349. doi: 10.1111/j.1476-5381.1957.tb00146.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vane J. R. The mode of action of aspirin and similar compounds. J Allergy Clin Immunol. 1976 Dec;58(6):691–712. doi: 10.1016/0091-6749(76)90181-0. [DOI] [PubMed] [Google Scholar]
  28. Zurier R. B., Quagliata F. Effect of prostaglandin E 1 on adjuvant arthritis. Nature. 1971 Dec 3;234(5327):304–305. doi: 10.1038/234304a0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES